Revive Therapeutics
  • Home
  • About
    • Management Team
    • Advisory Clinical Team
    • Board of Directors
  • Pipeline
    • Infectious Diseases
    • Intellectual Property
  • Investor
  • News
  • Contact
Select Page

Revive Therapeutics Announces Proposed Shares for Debt Transaction

by rvvadmin | Apr 21, 2025 | 2025

TORONTO, April 21, 2025 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, rare disorders, and...

Revive Therapeutics to Investigate Bucillamine’s Potential in Cancer Treatment

by rvvadmin | Apr 10, 2025 | 2025

TORONTO, April 10, 2025 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, rare disorders, and...

Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program

by rvvadmin | Apr 1, 2025 | 2025

TORONTO, April 01, 2025 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, rare disorders, and...

Revive Therapeutics Announces Results of Annual Shareholder Meeting

by rvvadmin | Mar 19, 2025 | 2025

TORONTO, March 19, 2025 –  Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, rare disorders, and...

Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program

by rvvadmin | Mar 3, 2025 | 2025

TORONTO, March 03, 2025 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, rare disorders, and...
« Older Entries

NEWS

2022

2021

2020

2019

Click Here for more news.
(Forwards to SEDAR website)

Privacy Policy

Disclaimer

  • Facebook
  • X
  • Instagram
© COPYRIGHT 2025. Revive Therapeutics Ltd. ALL RIGHTS RESERVED.